{"id":2401,"date":"2020-03-08T18:47:49","date_gmt":"2020-03-08T16:47:49","guid":{"rendered":"http:\/\/lupusgalicia.org\/?p=2401"},"modified":"2020-03-08T18:47:51","modified_gmt":"2020-03-08T16:47:51","slug":"las-complicaciones-oculares-en-el-les-estan-relacionadas-con-la-edad-y-la-toxicidad-de-los-tratamientos","status":"publish","type":"post","link":"https:\/\/lupusgalicia.org\/?p=2401","title":{"rendered":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Seg\u00fan un reciente\nestudio, las personas con lupus eritematosos sist\u00e9mico&nbsp;(LES) no\ntenemos muchas complicaciones oculares que est\u00e9n provocadas con la enfermedad\npero s\u00ed por la edad y por la toxicidad de algunos medicamentos que usamos. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El estudio\n\u00bb&nbsp;<a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/0961203320903080\">Participaci\u00f3n\nocular en pacientes con lupus eritematoso sist\u00e9mico: un cambio de paradigma\nbasado en la experiencia de un centro de referencia terciario<\/a>&nbsp;\u00ab,\nse public\u00f3 en la revista<em> Lupus.<\/em> En \u00e9l se afirma que alrededor de un\ntercio de los pacientes con LES desarrollan problemas oculares, los m\u00e1s\nfrecuentes son la queratoconjuntivitis seca&nbsp;(ojos secos) y el da\u00f1o\nretiniano (retinopat\u00eda).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La terapia con Hidroxicloroquina CQ) (Plaquenil\nentre otros nombres) ha ayudado a controlar la enfermedad y una disminuci\u00f3n de\nlas complicaciones oculares relacionadas con el LES (antes se usaba la\nCloroquina o Resoch\u00edn que ten\u00eda m\u00e1s toxicidad en ojo).&nbsp;\u00abEn los\n\u00faltimos a\u00f1os, hemos entrado en una nueva era en el tratamiento del LES\u00bb,\ndijeron los investigadores del departamento de oftalmolog\u00eda del&nbsp;Centro\nHospitalario y Universitario de Lisboa Central en Portugal. Ellos evaluaron la\ntasa de problemas oculares en un grupo de pacientes con LES y la compararon con\nla literatura existente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Evaluaron 161\npacientes: 145 mujeres (90,1%) y 16 hombres (9,9%) con una edad media de 47,6 y\nuna duraci\u00f3n media de la enfermedad de 11,5 a\u00f1os.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los ex\u00e1menes de\nla vista revelaron que 66 pacientes (41%) ten\u00edan al menos un signo de\nenfermedad ocular.&nbsp;Cuando los investigadores consideraron solo las\nmanifestaciones directamente relacionadas con enfermedades, como el s\u00edndrome\ndel ojo seco,&nbsp;cataratas, glaucoma, retinopat\u00eda por lupus y uve\u00edtis (una\nforma de inflamaci\u00f3n ocular), o con la toxicidad por HCQ, el n\u00famero de\npacientes con complicaciones oculares se redujo a 50 (31.1 %), \u00abUna\nproporci\u00f3n que est\u00e1 en l\u00ednea con estudios previos\u00bb, dijeron.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los problemas\noculares m\u00e1s frecuentes fueron s\u00edndrome de ojo seco (12.4%), cataratas o\ncirug\u00eda previa de cataratas (11.2%) y retinopat\u00eda relacionada con HCQ (tambi\u00e9n\n11.2%).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La mayor\u00eda de los\npacientes (80.7%) estaban siendo tratados con HCQ en el momento del\nestudio.&nbsp;Veintisiete hab\u00edan interrumpido el tratamiento y cuatro nunca\nhab\u00edan recibido HCQ.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dieciocho\npacientes (11,2%) ten\u00edan signos de toxicidad macular relacionada con el HCQ.&nbsp;La\nm\u00e1cula se encuentra en el centro de la retina y es responsable de la visi\u00f3n\ncentral y en color detallada.&nbsp;La toxicidad del tratamiento puede da\u00f1ar los\nbastones y los conos, dos tipos de c\u00e9lulas en la m\u00e1cula.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Solo un paciente\ncon maculopat\u00eda de ojo de buey,&nbsp; una forma de toxicidad macular, se quejaba\nde poca agudeza visual.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aquellos con\ntoxicidad macular eran significativamente mayores (edad media 54,9 a\u00f1os) que\nlos pacientes sin la complicaci\u00f3n (46,7 a\u00f1os).&nbsp;La dosis acumulada de HCQ y\nla duraci\u00f3n del tratamiento fueron m\u00e1s altas entre los pacientes con toxicidad\nmacular en comparaci\u00f3n con los no afectados (14,7 a\u00f1os en comparaci\u00f3n con 6,9\na\u00f1os).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El tratamiento\ncon HCQ se suspendi\u00f3 en todos los pacientes con toxicidad macular.&nbsp;En\ngeneral, la retirada de HCQ no dio lugar a una mayor actividad de la\nenfermedad.&nbsp;Sin embargo, en dos casos, la dosis de azatioprina, un\ninmunosupresor com\u00fanmente utilizado en enfermedades autoinmunes, se increment\u00f3\npara disminuir la actividad de la enfermedad.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En general, \u00abobservamos una reducci\u00f3n significativa en las complicaciones oft\u00e1lmicas directamente relacionadas con la actividad de la enfermedad sist\u00e9mica, particularmente la retinopat\u00eda por lupus\u00bb, dijeron.\u00a0\u00abPor otro lado, ha habido un aumento en las complicaciones oculares relacionadas con la medicaci\u00f3n y la edad, como la maculopat\u00eda por HCQ, cataratas y glaucoma\u00bb. \u00abEstos resultados resaltan la importancia de la detecci\u00f3n oft\u00e1lmica regular, incluso en pacientes con LES asintom\u00e1ticos y controlados sist\u00e9micamente\u00bb, dijeron los investigadores. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Noticia publicada en<a href=\"https:\/\/lupusnewstoday.com\/2020\/02\/19\/treatment-toxicity-and-age-linked-to-eye-complications-in-sle-study-suggests\/\"> LupusNewsToday<\/a> por la Dra Patricia Inacio, <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seg\u00fan un reciente estudio, las personas con lupus eritematosos sist\u00e9mico&nbsp;(LES) no tenemos muchas complicaciones oculares que est\u00e9n provocadas con la enfermedad pero s\u00ed por la edad y por la toxicidad de algunos medicamentos que usamos. El estudio \u00bb&nbsp;Participaci\u00f3n ocular en pacientes con lupus eritematoso sist\u00e9mico: un cambio de paradigma basado en la experiencia de un [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2402,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[14,6],"tags":[66,72],"class_list":["post-2401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-estudios","category-investigacion","tag-medicacion","tag-ojos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/lupusgalicia.org\/?p=2401\" \/>\r\n<meta property=\"og:locale\" content=\"es_ES\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus\" \/>\r\n<meta property=\"og:description\" content=\"Seg\u00fan un reciente estudio, las personas con lupus eritematosos sist\u00e9mico&nbsp;(LES) no tenemos muchas complicaciones oculares que est\u00e9n provocadas con la enfermedad pero s\u00ed por la edad y por la toxicidad de algunos medicamentos que usamos. El estudio \u00bb&nbsp;Participaci\u00f3n ocular en pacientes con lupus eritematoso sist\u00e9mico: un cambio de paradigma basado en la experiencia de un [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/lupusgalicia.org\/?p=2401\" \/>\r\n<meta property=\"og:site_name\" content=\"Asociaci\u00f3n Galega de Lupus\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LupusGalicia\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2020-03-08T16:47:49+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2020-03-08T16:47:51+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\r\n\t<meta property=\"og:image:height\" content=\"667\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"Agal\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:creator\" content=\"@LupusGalicia\" \/>\r\n<meta name=\"twitter:site\" content=\"@LupusGalicia\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#article\",\"isPartOf\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401\"},\"author\":{\"name\":\"Agal\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665\"},\"headline\":\"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos.\",\"datePublished\":\"2020-03-08T16:47:49+00:00\",\"dateModified\":\"2020-03-08T16:47:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401\"},\"wordCount\":673,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/lupusgalicia.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg\",\"keywords\":[\"medicaci\u00f3n\",\"ojos\"],\"articleSection\":[\"Estudios\",\"Investigaci\u00f3n\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/lupusgalicia.org\/?p=2401#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401\",\"url\":\"https:\/\/lupusgalicia.org\/?p=2401\",\"name\":\"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus\",\"isPartOf\":{\"@id\":\"https:\/\/lupusgalicia.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg\",\"datePublished\":\"2020-03-08T16:47:49+00:00\",\"dateModified\":\"2020-03-08T16:47:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lupusgalicia.org\/?p=2401\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#primaryimage\",\"url\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg\",\"contentUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg\",\"width\":1000,\"height\":667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2401#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/lupusgalicia.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lupusgalicia.org\/#website\",\"url\":\"https:\/\/lupusgalicia.org\/\",\"name\":\"Asociaci\u00f3n Galega de Lupus\",\"description\":\"Trabajando para y por las personas con Lupus\",\"publisher\":{\"@id\":\"https:\/\/lupusgalicia.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lupusgalicia.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lupusgalicia.org\/#organization\",\"name\":\"Asociaci\u00f3n Galega de Lupus\",\"url\":\"https:\/\/lupusgalicia.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png\",\"contentUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png\",\"width\":2560,\"height\":2522,\"caption\":\"Asociaci\u00f3n Galega de Lupus\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LupusGalicia\/\",\"https:\/\/x.com\/LupusGalicia\",\"https:\/\/www.instagram.com\/lupusgalicia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665\",\"name\":\"Agal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"caption\":\"Agal\"},\"description\":\"AGAL. Asociaci\u00f3n Galega de Lupus. Creada en 1997. Pretendemos dar informaci\u00f3n sobre el Lupus y que la enfermedad deje de ser una gran desconocida; ayudar a familiares y amigos; promover investigaci\u00f3n; divulgar y relacionar a nuestros asociados a trav\u00e9s de Jornadas, la revista Papilio, charlas, reuniones...\",\"sameAs\":[\"http:\/\/www.lupusgalicia.org\"],\"url\":\"https:\/\/lupusgalicia.org\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lupusgalicia.org\/?p=2401","og_locale":"es_ES","og_type":"article","og_title":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus","og_description":"Seg\u00fan un reciente estudio, las personas con lupus eritematosos sist\u00e9mico&nbsp;(LES) no tenemos muchas complicaciones oculares que est\u00e9n provocadas con la enfermedad pero s\u00ed por la edad y por la toxicidad de algunos medicamentos que usamos. El estudio \u00bb&nbsp;Participaci\u00f3n ocular en pacientes con lupus eritematoso sist\u00e9mico: un cambio de paradigma basado en la experiencia de un [&hellip;]","og_url":"https:\/\/lupusgalicia.org\/?p=2401","og_site_name":"Asociaci\u00f3n Galega de Lupus","article_publisher":"https:\/\/www.facebook.com\/LupusGalicia\/","article_published_time":"2020-03-08T16:47:49+00:00","article_modified_time":"2020-03-08T16:47:51+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg","type":"image\/jpeg"}],"author":"Agal","twitter_card":"summary_large_image","twitter_creator":"@LupusGalicia","twitter_site":"@LupusGalicia","twitter_misc":{"Escrito por":"Agal","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lupusgalicia.org\/?p=2401#article","isPartOf":{"@id":"https:\/\/lupusgalicia.org\/?p=2401"},"author":{"name":"Agal","@id":"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665"},"headline":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos.","datePublished":"2020-03-08T16:47:49+00:00","dateModified":"2020-03-08T16:47:51+00:00","mainEntityOfPage":{"@id":"https:\/\/lupusgalicia.org\/?p=2401"},"wordCount":673,"commentCount":0,"publisher":{"@id":"https:\/\/lupusgalicia.org\/#organization"},"image":{"@id":"https:\/\/lupusgalicia.org\/?p=2401#primaryimage"},"thumbnailUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg","keywords":["medicaci\u00f3n","ojos"],"articleSection":["Estudios","Investigaci\u00f3n"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lupusgalicia.org\/?p=2401#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lupusgalicia.org\/?p=2401","url":"https:\/\/lupusgalicia.org\/?p=2401","name":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos. - Asociaci\u00f3n Galega de Lupus","isPartOf":{"@id":"https:\/\/lupusgalicia.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lupusgalicia.org\/?p=2401#primaryimage"},"image":{"@id":"https:\/\/lupusgalicia.org\/?p=2401#primaryimage"},"thumbnailUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg","datePublished":"2020-03-08T16:47:49+00:00","dateModified":"2020-03-08T16:47:51+00:00","breadcrumb":{"@id":"https:\/\/lupusgalicia.org\/?p=2401#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lupusgalicia.org\/?p=2401"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/lupusgalicia.org\/?p=2401#primaryimage","url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg","contentUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2020\/03\/shutterstock_272614787-1000x480@2x.jpg","width":1000,"height":667},{"@type":"BreadcrumbList","@id":"https:\/\/lupusgalicia.org\/?p=2401#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/lupusgalicia.org\/"},{"@type":"ListItem","position":2,"name":"Las complicaciones oculares en el LES est\u00e1n relacionadas con la edad y la toxicidad de los tratamientos."}]},{"@type":"WebSite","@id":"https:\/\/lupusgalicia.org\/#website","url":"https:\/\/lupusgalicia.org\/","name":"Asociaci\u00f3n Galega de Lupus","description":"Trabajando para y por las personas con Lupus","publisher":{"@id":"https:\/\/lupusgalicia.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lupusgalicia.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/lupusgalicia.org\/#organization","name":"Asociaci\u00f3n Galega de Lupus","url":"https:\/\/lupusgalicia.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/","url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png","contentUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png","width":2560,"height":2522,"caption":"Asociaci\u00f3n Galega de Lupus"},"image":{"@id":"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LupusGalicia\/","https:\/\/x.com\/LupusGalicia","https:\/\/www.instagram.com\/lupusgalicia\/"]},{"@type":"Person","@id":"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665","name":"Agal","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","caption":"Agal"},"description":"AGAL. Asociaci\u00f3n Galega de Lupus. Creada en 1997. Pretendemos dar informaci\u00f3n sobre el Lupus y que la enfermedad deje de ser una gran desconocida; ayudar a familiares y amigos; promover investigaci\u00f3n; divulgar y relacionar a nuestros asociados a trav\u00e9s de Jornadas, la revista Papilio, charlas, reuniones...","sameAs":["http:\/\/www.lupusgalicia.org"],"url":"https:\/\/lupusgalicia.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2401"}],"version-history":[{"count":1,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2401\/revisions"}],"predecessor-version":[{"id":2403,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2401\/revisions\/2403"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/media\/2402"}],"wp:attachment":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}